Cannabis-based spray for severe itching that hasn't improved
Treatments studied
Part of Skin clinical trials.
This study tests whether a cannabis-based oral spray (with equal parts THC and CBD) can safely reduce severe itching when other treatments haven't helped. It compares the spray to an inactive placebo to see if it truly works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your itching is severe (7 or higher on a 0–10 scale) despite trying other treatments.
- Your itch treatment has been stable (unchanged) for at least 6 weeks before starting.
- You are willing to stop using cannabis or cannabis products for the entire study.
- You do not have severe liver, kidney, heart, or brain disease, a psychotic disorder, or a nut allergy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether combining hypnosis with virtual reality can reduce chronic itch. It may help if you have had itching for at least a year, seen a doctor for it, and it still affects your daily life despite treatment.
This Phase 3 study tests whether dupilumab injections can reduce severe itching that has no clear cause. It also checks how safe the medicine is over the study period.
This study tests a light-based therapy (called photobiomodulation) to see if it can reduce itch. The treatment uses a special light on the skin, which may help calm the nerves or cells that cause itching. You'll have one side of your body treated and the other side not, so the researchers can compare the effects.
This study tests a cannabis-based cream on eczema-related itch over 4 weeks. It may help reduce itching if other treatments haven't worked, but requires pausing other skin products during the trial.
This study tests if applying several itch-causing substances at once makes you itch more. It is for healthy adults who want to help researchers understand itch better.
This study tests an investigational medicine (remibrutinib) for people with severe itching that has no known cause. It may help reduce the itch when moisturizers haven't worked.
Hear when a new Pruritus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.